NCT02661139

Brief Summary

The investigators aim to develop a prospective database in which patient demographics, surgical, dental, prosthetic and QOL parameters collected during consecutive visits within the framework of routine practice, are being registered for each oncological patient eligible for (immediate/delayed) fixed prosthodontic rehabilitation at time of oral cavity reconstruction

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Jun 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jun 2013Dec 2027

Study Start

First participant enrolled

June 1, 2013

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 22, 2016

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Expected
Last Updated

February 28, 2022

Status Verified

February 1, 2022

Enrollment Period

9.5 years

First QC Date

January 11, 2016

Last Update Submit

February 23, 2022

Conditions

Keywords

bisphosphonatesjaw reconstructionprosthetic rehabilitationquality of lifemonoclonal antibodies' targeted therapy

Outcome Measures

Primary Outcomes (6)

  • implant survival rate

    within 12 months postoperative

  • bone resorption, as evaluated with cone-beam computed tomography

    within 12 months postoperative

  • prosthesis survival rate

    within 12 months postoperative

  • implant survival rate

    within 60 months postoperative

  • bone resorption, as evaluated with cone-beam computed tomography

    within 60 months postoperative

  • prosthesis survival rate

    within 60 months postoperative

Secondary Outcomes (3)

  • Prevalence of oncological patients requiring jaw reconstruction secondary to tumour resection, ORN or MRONJ

    within 12 months postoperative

  • Potential biologic or mechanical risk factors predictive of undesirable functional or aesthetic outcomes, through regression analysis

    within 60 months postoperative

  • Patient' quality of life after prosthetic rehabilitation

    until a maximum of 60 months follow-up

Other Outcomes (1)

  • patient satisfaction, as measured through visual analogue scale

    until a maximum of 60 months follow-up

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consenting patients with a histologically confirmed oncology diagnosis that requires major ablative surgery of the oral cavity, including segmental or total jaw resection, due to head and neck cancer, ORN or MRONJ

You may qualify if:

  • Patients of all ages
  • Patients of all genders
  • Patients with a histologically or clinically confirmed diagnosis of ORN, MRONJ, as classified by Ruggiero et al. (Ruggiero, et al., 2014) or carcinoma located in the oral cavity and jawbone, requiring segmental or total jaw resection
  • Patients eligible for jaw and oral cavity reconstruction combined with immediate/delayed implant loading for fixed prosthetic rehabilitation
  • Patients not eligible for conventional removable prosthetic rehabilitation

You may not qualify if:

  • Patients with a clinically confirmed diagnosis of osteonecrosis not related to an oncological diagnosis or treatment
  • Patients with medical contraindications for jaw reconstruction combined with immediate implant loading for fixed prosthetic rehabilitation
  • Patients eligible for conventional removable prosthetic rehabilitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital Saint-John Bruges

Bruges, Belgium

RECRUITING

MeSH Terms

Conditions

Head and Neck NeoplasmsOsteonecrosisOsteoradionecrosis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsRadiation InjuriesWounds and Injuries

Study Officials

  • Johan Abeloos, MD

    Department of Oral and Maxillofacial Surgery, General Hospital Saint-John Bruges, Bruges, Belgium

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Araceli Diez-Fraile, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maxillofacial surgeon, Head of Department

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 22, 2016

Study Start

June 1, 2013

Primary Completion

December 1, 2022

Study Completion (Estimated)

December 1, 2027

Last Updated

February 28, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations